Ranbaxy Laboratories Limited,(www.ranbaxy.com) India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. The Company is ranked amongst the top ten global generic companies and has a presence in 23 of the top 25 pharma markets of the world. The Company with a global footprint in 49 countries, world-class manufacturing facilities in 11 and a diverse product portfolio, is rapidly moving towards global leadership, riding on its success in the world’s emerging.

Ranbaxy is focused on increasing the momentum in the generics business in its key markets through organic and inorganic growth routes. It continues to evaluate acquisition opportunities in India, emerging and developed markets to accentuate its business and competitiveness. The Company’s growth is well spread across geographies with near equal focus on developed and emerging markets. Ranbaxy has entered into new speciality therapeutic segments like Bio-similars, Oncology, Peptides and Limuses. These new growth areas will add significant depth to its existing product pipeline.

Ranbaxy today has a pool of over 1,200 scientists engaged in path-breaking research. Driven by the passion of its over 12,000 strong multicultural workforce comprising 50 nationalities. Ranbaxy continues to aggressively pursue its mission to become a Research-based International Pharmaceutical Company and attain a true global leadership position.

The warehouse operations through the territory of FARMAT should be commencing from the 1st week of Dec 2008, upon receipt of the Pharma license.